Bio-Identical HGH Therapy is widely used in the United States for the treatment of Age-Related Growth Hormone Deficiency, as a means to mitigate the symptoms of HGH Decline. This condition is also known as Somatic Senescence. Our bodies naturally produce less and less Human Growth Hormone, the older that we get, and this is embedded into the way that our bodies age. Signs strongly suggest that the physiological changes that take place resulting from Age-Related Human Growth Hormone Deficiency break down our body’s ability to repair and rejuvenate itself, exacerbating many issues related to aging.
Sermorelin is increasing in popularity among Hormone Doctors and Medical Practitioners as opposed to HGH Therapy, however. One reason is that there hasn’t been sufficient study to evaluate the long-term effects of Human Growth Hormone Deficiency. Another reason is that there are strong regulations in place which prevent licensed and board certified Hormone Physicians from using HGH Injections to their full extent.
Issues Related to the Prescription of Bio-Identical HGH Therapy:
- Because Human Growth Hormone Injections are a scheduled drug, they cannot be prescribed off-label, and thus are only available to adults suffering from HGH Deficiency or HIV/AIDS-Wasting Disease.
- HGH Therapy does not accurately reflect the manner in which the body naturally produces HGH, which reduces the body’s ability to produce its own Growth Hormone.
- If patients chronically receive too much Human Growth Hormone, it can lead to detrimental side-effects.
There is a lot of data available with regard to patients with Growth Hormone Deficiency of a pathological cause, but there is much less data available with regard to the use of HGH for Age-Related Growth Hormone Decline. It is clear that, for patients with significant HGH Deficiency of a pathological source, that HGH Injections can significantly improve long-term health and reduce mortality risk, the data is insufficient to conclusively make the same claim for patients with age-related HGH Deficiency.
Potential Risks of HGH Therapy for Growth Hormone Deficiency
There are also some unanswered questions with regard to the use of HGH Injection Therapy for such purposes. For example, there is some debate with regard to how Human Growth Hormone Treatments may increase cancer risk, or if patients receive too much HGH, it could increase the risk of health issues like diabetes. There is also the issue with how suppressing Growth Hormone Production by the Pituitary may impact the balance of other hormones produced by the body. These issues have all been unanswered, though no overwhelming evidence has been presented in their favor.
There are other issues related to HGH Injection Therapy that have been noted, and are inherent in the use of the treatment. For example, since Injectable Growth Hormone is delivered once-daily in subcutaneous fashion, there is no way to encourage the body to use the HGH in a natural fashion, as the hormone is immediately metabolized and absorbed. There are no natural forces in place to control the absorption of HGH introduced into the blood stream. Over time, the use of Injectable Growth Hormone in this fashion can lead to a reduction in the total effectiveness of the treatment.
There is also no effective means to exactly diagnose the level of HGH Deficiency, and provide the perfect level of treatment, because HGH Deficiency diagnosis is the result of analyzing IGF-1 levels, in combination with the patient’s self-evaluated experience of symptoms.
There is a treatment available that can mitigate many of the factors which make HGH Injection Therapy less-than-ideal, while also encouraging the body to maintain normal and healthy Growth Hormone Levels. Sermorelin Therapy is a Growth Hormone Alternative that has been shown to be just as effective as HGH Therapy in the short term while reducing the risk of side-effects and other issues that are related to long-term treatment. Sermorelin is derived from a hormone produced naturally by the human body, known as GH-RH, or Growth Hormone-Releasing Hormone. The medication is also known as 1-29 NH2-Acetate, as it is comprised of the first 29 amino acids of naturally-occurring GH-RH.
Sermorelin is increasing in popularity among both patients and their doctors, because it provides many of the great benefits of HGH Therapy for patients with Adult-Onset HGH Deficiency, while avoiding some of the potential pitfalls. Anti-Aging Clinics and Longevity Specialists have begun to turn to Sermorelin as opposed to Bio-Identical HGH for this reason. Neither Sermorelin nor HGH are Anti-Aging Drugs, but both can be useful tools in restoring Hormone Balance for patients.
In the future there may be other treatments available—for example, there are GH-RH Peptides under development, but they are still in preliminary phases. Some clinical evidence even shows that they may enhance physical capacity in older patients. Whereas these other treatments will potentially be available in the future, Sermorelin Acetate is being prescribed and has been shown to be effective today, and for patients with Adult-Onset HGH Deficiency, Sermorelin is largely the better option available.
Sermorelin First Invented as a Pediatric Growth Hormone Deficiency Treatment
Sermorelin was created as a treatment for children with HGH Deficiency, but Injectable HGH was found to be more effective for this purpose, and is no longer used as a pediatric HGH Deficiency treatment. Sermorelin can’t induce the elevated HGH Levels necessary to encourage growth in children, but evidence strongly shows that it can encourage production of Human Growth Hormone that is physiologically normal for a young adult, meaning that it can help patients that are experiencing Somatopause experience a more ideal hormone state facilitated by the release of their own natural hormones. Furthermore, there are many distinct benefits of Sermorelin over Human Growth Hormone, owing directly to the way that it is processed by the body:
- Sermorelin encourages more normalized patterns of Human Growth Hormone Release than Bio-Identical HGH, which is metabolized fully and at-once.
- Because Sermorelin encourages a more physiologically natural release of HGH, the body does not display any risk of reduced sensitity to the hormone, or tachyphylaxis.
- Negative-feedback mechanisms prevent the body from producing an overdose of HGH, primarily through the release of Somatostatin, a hormone which blocks the activation of GH-RH receptor sites on the pituitary.
- Sermorelin maintains the normal function of the Hypophyseal Portal System which transports hormones from the Hypothalamus to the Pituitary.
- Sermorelin effectively preserves natural Hormone Balance, keeping the neuroendocrine system running in a more optimized pattern.
Legal Restrictions on HGH Make Sermorelin More Popular
One major road-block with regard to Human Growth Hormone Therapy is that it is highly restricted in how it can be used, moreso than the vast majority of other prescription drugs. Sermorelin Therapy, on the other hand, can be prescribed by a licensed and board-certified Hormone Doctor at his or her discretion. Because of the risks inherent with the prescription of such tightly controlled drugs, Sermorelin is growing in popularity because it provides the same benefits with distinct advantages for most patients, without the risk. Aside from that, Sermorelin is cheaper than Bio-Identical HGH Therapy, meaning that patients prefer it for budget reasons as well.